Changi General Hospital
Singapore, 529889
NCT Number: NCT05169528
Cancer prehabilitation typically involves multiple pre-op visits. The investigators aim to assess the impact of their novel model, a "one-stop "service by a small, "levelled-up" core team on newly diagnosed colorectal cancer patients planned for surgery.
Looking for future studies?
Notify Me21 year–99 year
All sexes
Interventional
Not applicable
Singapore, 529889
Objective Cancer prehabilitation typically involves multiple pre-op visits. The investigators aim to assess the impact of their novel model, a "one-stop "service by a small, "levelled-up" core team on newly diagnosed colorectal cancer patients planned for surgery.
Design This is a before-after trial in a tertiary public hospital in Singapore, involving all newly diagnosed colorectal cancer patients planned for surgery who are referred to the Cancer Prehabilitation Program. The primary outcome measure is the 6-minute-walk-test. Others include physical, psychological, quality-of-life and post-operative measures, and patient-satisfaction-surveys, taken at baseline, pre-operatively (post-prehabilitation), and 3-months-post-operatively.
Keywords: Colorectal; Cancer Prehabilitation; Novel; Model of Care
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Assessment and Interventions involving the Prehabilitative domains of medical optimisation, exercise prescription, nutrition and mental health optimisation
Time frame: Baseline
Distance walked in 6 minutes under standardised conditions
Time frame: Pre-Operatively (after prehabilitation)
Distance walked in 6 minutes under standardised conditions
Time frame: Post-Operatively (3 months)
Distance walked in 6 minutes under standardised conditions
Time frame: Baseline
Number of repetitions of sit-to-stand within 30 seconds
Time frame: Pre-Operatively (after prehabilitation)
Number of repetitions of sit-to-stand within 30 seconds
Time frame: Post-Operatively (3 months)
Number of repetitions of sit-to-stand within 30 seconds
Time frame: Baseline
Divided into Anxiety (0-21 points) and Depression scale (0-21 points), the higher the worser
Time frame: Pre-Operatively (after prehabilitation)
Divided into Anxiety (0-21 points) and Depression scale (0-21 points), the higher the worser
Time frame: Post-Operatively (3 months)
Divided into Anxiety (0-21 points) and Depression scale (0-21 points), the higher the worser
Time frame: Baseline
Health Score (visual analogue scale from 0-100), the higher the better
Time frame: Post-Operatively (3 months)
Health Score (visual analogue scale from 0-100), the higher the better
Time frame: From Date of Admission for Surgery till Date of Discharge, assessed up to 100 weeks
Post-Operative Hospital Length of Stay
Time frame: From Surgery till 30 Days Post-op
30-Day Post-Operative Major Complications
Time frame: From Surgery till 30 Days Post-op
30-Day Post-Operative Readmission Rates
Time frame: From Surgery till 30 Days Post-op
30-Day Post-Operative Mortality
Time frame: Pre-Operatively (after prehabilitation)
Patient Satisfaction Survey
Time frame: Post-Operatively (3 months)
Patient Satisfaction Survey
Changi General Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02970513
Bacterial Infections, Bacterial Infections and Mycoses
Clermont-Ferrand, France
View Trial DetailsNCT06068257
Breast Cancer, Breast Diseases
Orlando, Florida, United States
View Trial DetailsNCT07725692
Anastomotic Leak, Colon Cancer
Alexandria, Please Select, Egypt
View Trial DetailsNCT07180303
Colonic Diseases, Colorectal Cancer
Liyang, Jiangsu, China
View Trial Details